FORMYCON AG (FYB.DE) Fundamental Analysis & Valuation

FRA:FYB • DE000A1EWVY8

Current stock price

17.66 EUR
-0.16 (-0.9%)
Last:

This FYB.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. FYB.DE Profitability Analysis

1.1 Basic Checks

  • In the past year FYB has reported negative net income.
  • In the past year FYB had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: FYB reported negative net income in multiple years.
  • In the past 5 years FYB always reported negative operating cash flow.
FYB.DE Yearly Net Income VS EBIT VS OCF VS FCFFYB.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

  • FYB has a Return On Assets (-22.86%) which is in line with its industry peers.
  • Looking at the Return On Equity, with a value of -41.58%, FYB is in the better half of the industry, outperforming 60.76% of the companies in the same industry.
Industry RankSector Rank
ROA -22.86%
ROE -41.58%
ROIC N/A
ROA(3y)-1.19%
ROA(5y)-6.14%
ROE(3y)-0.68%
ROE(5y)-7.18%
ROIC(3y)N/A
ROIC(5y)N/A
FYB.DE Yearly ROA, ROE, ROICFYB.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

  • FYB does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FYB.DE Yearly Profit, Operating, Gross MarginsFYB.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. FYB.DE Health Analysis

2.1 Basic Checks

  • FYB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • FYB has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, FYB has more shares outstanding
  • The debt/assets ratio for FYB has been reduced compared to a year ago.
FYB.DE Yearly Shares OutstandingFYB.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
FYB.DE Yearly Total Debt VS Total AssetsFYB.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • FYB has an Altman-Z score of 0.30. This is a bad value and indicates that FYB is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of FYB (0.30) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.02 indicates that FYB is not too dependend on debt financing.
  • FYB has a better Debt to Equity ratio (0.02) than 79.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 0.3
ROIC/WACCN/A
WACC7.21%
FYB.DE Yearly LT Debt VS Equity VS FCFFYB.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

  • A Current Ratio of 1.54 indicates that FYB should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.54, FYB is not doing good in the industry: 62.03% of the companies in the same industry are doing better.
  • A Quick Ratio of 1.51 indicates that FYB should not have too much problems paying its short term obligations.
  • FYB has a Quick ratio (1.51) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.54
Quick Ratio 1.51
FYB.DE Yearly Current Assets VS Current LiabilitesFYB.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. FYB.DE Growth Analysis

3.1 Past

  • FYB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -339.98%.
  • The Revenue for FYB has decreased by -14.84% in the past year. This is quite bad
  • The Revenue has been growing by 15.48% on average over the past years. This is quite good.
EPS 1Y (TTM)-339.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-425.42%
Revenue 1Y (TTM)-14.84%
Revenue growth 3Y23.92%
Revenue growth 5Y15.48%
Sales Q2Q%0.03%

3.2 Future

  • Based on estimates for the next years, FYB will show a very strong growth in Earnings Per Share. The EPS will grow by 48.97% on average per year.
  • Based on estimates for the next years, FYB will show a very strong growth in Revenue. The Revenue will grow by 21.50% on average per year.
EPS Next Y12.95%
EPS Next 2Y32.71%
EPS Next 3Y48.97%
EPS Next 5YN/A
Revenue Next Year-9.62%
Revenue Next 2Y19.01%
Revenue Next 3Y25.28%
Revenue Next 5Y21.5%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
FYB.DE Yearly Revenue VS EstimatesFYB.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M
FYB.DE Yearly EPS VS EstimatesFYB.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2

More info and screens

Find the best growth stocksShow best growing peers

2

4. FYB.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for FYB. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for FYB. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FYB.DE Price Earnings VS Forward Price EarningsFYB.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60 -60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, FYB is valued cheaper than 96.20% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.58
FYB.DE Per share dataFYB.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • A more expensive valuation may be justified as FYB's earnings are expected to grow with 48.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.71%
EPS Next 3Y48.97%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. FYB.DE Dividend Analysis

5.1 Amount

  • No dividends for FYB!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

FYB.DE Fundamentals: All Metrics, Ratios and Statistics

FORMYCON AG

FRA:FYB (3/27/2026, 7:00:00 PM)

17.66

-0.16 (-0.9%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-13
Earnings (Next)04-23
Inst Owners7.06%
Inst Owner ChangeN/A
Ins Owners3.28%
Ins Owner ChangeN/A
Market Cap312.05M
Revenue(TTM)51.78M
Net Income(TTM)-169.77M
Analysts83.08
Price Target50.71 (187.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)13.28%
Min Revenue beat(2)-63.69%
Max Revenue beat(2)90.24%
Revenue beat(4)2
Avg Revenue beat(4)18.75%
Min Revenue beat(4)-63.69%
Max Revenue beat(4)90.24%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.25%
PT rev (3m)1.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)38.81%
EPS NY rev (3m)53.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.76%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.03
P/FCF N/A
P/OCF 21.14
P/B 0.76
P/tB N/A
EV/EBITDA 2.58
EPS(TTM)-9.6
EYN/A
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)-1.26
FCFYN/A
OCF(TTM)0.84
OCFY4.73%
SpS2.93
BVpS23.11
TBVpS-2.71
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -22.86%
ROE -41.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-1.19%
ROA(5y)-6.14%
ROE(3y)-0.68%
ROE(5y)-7.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA 0.08
Cap/Depr 24.47%
Cap/Sales 71.59%
Interest Coverage N/A
Cash Conversion 12.89%
Profit Quality N/A
Current Ratio 1.54
Quick Ratio 1.51
Altman-Z 0.3
F-Score3
WACC7.21%
ROIC/WACCN/A
Cap/Depr(3y)860.64%
Cap/Depr(5y)536.06%
Cap/Sales(3y)44.41%
Cap/Sales(5y)27.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-339.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-425.42%
EPS Next Y12.95%
EPS Next 2Y32.71%
EPS Next 3Y48.97%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.84%
Revenue growth 3Y23.92%
Revenue growth 5Y15.48%
Sales Q2Q%0.03%
Revenue Next Year-9.62%
Revenue Next 2Y19.01%
Revenue Next 3Y25.28%
Revenue Next 5Y21.5%
EBIT growth 1Y-49.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-104.1%
EBIT Next 3Y92.98%
EBIT Next 5Y71.8%
FCF growth 1Y58.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y186.39%
OCF growth 3YN/A
OCF growth 5YN/A

FORMYCON AG / FYB.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of FORMYCON AG (FYB.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to FYB.DE.


What is the valuation status of FORMYCON AG (FYB.DE) stock?

ChartMill assigns a valuation rating of 2 / 10 to FORMYCON AG (FYB.DE). This can be considered as Overvalued.


What is the profitability of FYB stock?

FORMYCON AG (FYB.DE) has a profitability rating of 1 / 10.


How financially healthy is FORMYCON AG?

The financial health rating of FORMYCON AG (FYB.DE) is 3 / 10.


Can you provide the expected EPS growth for FYB stock?

The Earnings per Share (EPS) of FORMYCON AG (FYB.DE) is expected to grow by 12.95% in the next year.